IP Library › Granted Patent US 12,564,339
Granted Patent B2
US 12,564,339 · App. 18/497,827 · Granted Mar 3, 2026

Autoregulation monitoring using deep learning

Inventors: Dean Montgomery (Edinburgh, GB); Paul S. Addison (Edinburgh, GB); Andre Antunes (Edinburgh, GB)
Assignee: Covidien LP
A61B5/14553A61B5/7264
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,564,339
App. No.
18/497,827
Granted
Mar 3, 2026
Kind
B2
Abstract

In some examples, a system is configured to determine, using a neural network algorithm of a cerebral autoregulation model, a cerebral autoregulation status of the patient based at least in part on a blood pressure of the patient over a period of time and regional cerebral oxygen saturation of the patient over the period of time.

Claims (41)

1 . A system, comprising:

an output device to display an autoregulation status of a patient;

processing circuitry communicatively coupled to the output device; and

memory storing instructions that, when executed by the processing circuitry, cause the processing circuitry to perform operations, comprising:

receive a regional oxygen saturation signal indicative of a regional oxygen saturation of the patient during a period of time;

receive a blood pressure signal indicative of a blood pressure of the patient during the period of time;

determine, via an autoregulation model, the autoregulation status of the patient based on the regional oxygen saturation signal and the blood pressure signal, wherein the autoregulation model is trained via machine learning over training data to classify the autoregulation status of the patient as one of impaired, intact, or unknown based on comparing two or more confidence scores associated with the autoregulation status of the patient; and

instruct the output device to present a graphical user interface (GUI) to display the autoregulation status of the patient.

2 . The system of claim 1 , wherein the autoregulation model is trained via machine learning over the training data to classify the autoregulation status of the patient based on comparing a first confidence score of the two or more confidence scores associated with the autoregulation status of the patient being intact with a second confidence score of the two or more confidence scores associated with the autoregulation status of the patient being impaired.

3 . The system of claim 1 , wherein the instructions, when executed by the processing circuitry, cause the processing circuitry to provide an age of the patient, a diet of the patient, a lifestyle of the patient, or any combination thereof to the autoregulation model to determine the autoregulation status.

4 . The system of claim 1 , wherein the instructions, when executed by the processing circuitry, cause the processing circuitry to perform further operations, comprising:

determine a respective gradient of the regional oxygen saturation of the patient over the period of time;

determine a respective gradient of the blood pressure of the patient over the period of time; and

provide the respective gradient of the regional oxygen saturation and the respective gradient of the blood pressure to the autoregulation model to determine the autoregulation status.

5 . The system of claim 1 , wherein the instructions, when executed by the processing circuitry, cause the processing circuitry to instruct the output device to update the GUI to display at least one of the blood pressure of the patient, the regional oxygen saturation of the patient, a pulse rate of the patient, or a respiration rate of the patient.

6 . The system of claim 1 , wherein the instructions, when executed by the processing circuitry, cause the processing circuitry to perform further operations, comprising:

instruct the output device to present the GUI to display a first zone representing an intact autoregulation zone for the patient, a second zone representing an impaired autoregulation zone for the patient, and the blood pressure overlaid onto the first zone, the second zone, or both.

7 . The system of claim 6 , wherein the instructions, when executed by the processing circuitry, cause the processing circuitry to perform further operations, comprising:

determine a threshold autoregulation value;

determine a first region above the threshold autoregulation value being the first zone; and

determine a second region below the threshold autoregulation value being the second zone.

8 . The system of claim 1 , wherein the period of time is 30 seconds, 60 seconds, 90 seconds, or 120 seconds.

9 . A method comprising:

receiving, via processing circuitry, a blood pressure signal indicative of a blood pressure of a patient over a period of time;

receiving, via the processing circuitry, an oxygen saturation signal indicative of a regional oxygen saturation of the patient over the period of time;

inputting, via the processing circuitry, the blood pressure of the patient over the period of time and the regional oxygen saturation of the patient over the period of time into an autoregulation model to determine an autoregulation status of the patient, wherein the autoregulation model is trained via machine learning over training data to classify the autoregulation status of the patient as one of impaired, intact, or unknown based on comparing two or more confidence scores associated with the autoregulation status of the patient; and

instructing, via the processing circuitry, an output device to display the autoregulation status of the patient.

10 . The method of claim 9 , further comprising:

inputting, via the processing circuitry, the blood pressure of the patient over the period of time and the regional oxygen saturation of the patient over the period of time into the autoregulation model to:

determine a first confidence score of the two or more confidence scores, wherein the first confidence score is associated with the autoregulation status of the patient being intact;

determine a second confidence score of the two or more confidence scores, wherein the second confidence score is associated with the autoregulation status of the patient being impaired; and

classify the autoregulation status of the patient based on comparing the first confidence score and the second confidence score to determine the autoregulation status of the patient.

11 . The method of claim 9 , wherein instructing, via the processing circuitry, the output device to display the autoregulation status comprises:

instructing the output device to display a graph comprising a first region associated with an intact autoregulation zone for the patient, a second region associated with an impaired autoregulation zone for the patient, and the blood pressure overlaid onto at least one of the intact autoregulation zone or the impaired autoregulation zone.

12 . The method of claim 9 , comprising inputting, via the processing circuitry, a bypass flag into the autoregulation model to determine the autoregulation status of the patient during a cardiopulmonary bypass procedure.

13 . The method of claim 9 , comprising:

providing, via the processing circuitry, the training data comprising one or more of the blood pressure signal, the oxygen saturation signal, or the autoregulation status to the autoregulation model.

14 . The method of claim 9 , comprising:

providing, via the processing circuitry, the training data comprising one or more of a plurality of mean arterial pressures over additional periods of time, a plurality of regional oxygen saturation values over the additional periods of time, and a respective plurality of truth labels that correspond to the plurality of mean arterial pressures and the plurality of regional oxygen saturation values to train the autoregulation model, wherein each truth label of the plurality of truth labels indicates the autoregulation status as either an intact autoregulation status or an impaired autoregulation status.

15 . The method of claim 9 , comprising:

in response to receiving at least one of the blood pressure signal or the oxygen saturation signal, cleaning, via the processing circuitry, the at least one of the blood pressure signal, the oxygen saturation signal, or both.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2023
From: MONTGOMERY, DEAN; ADDISON, PAUL S.; ANTUNES, ANDRE
To: COVIDIEN LP
Reel/Frame 065402/0491 →
Continuity (2)
Continuation 17210222 · Mar 23, 2021
Related Publication 20240057904A1 · Feb 22, 2024
References Cited (58)
US 5743267A · Nikolic et al. · 1998 [cited by applicant]
US 6599251B2 · Chen et al. · 2003 [cited by applicant]
US 6689069B2 · Bratteli et al. · 2004 [cited by applicant]
US 7070566B2 · Medero et al. · 2006 [cited by applicant]
US 7927283B2 · Riobo et al. · 2011 [cited by applicant]
US 8366627B2 · Kashif et al. · 2013 [cited by applicant]
US 8702604B2 · Karamanoglu et al. · 2014 [cited by applicant]
US 9474451B2 · Brady et al. · 2016 [cited by applicant]
US 9861317B2 · Ochs · 2018 [cited by applicant]
US 10542923B2 · Chang et al. · 2020 [cited by applicant]
US 10595790B2 · Itu et al. · 2020 [cited by applicant]
US 10660530B2 · Montgomery et al. · 2020 [cited by applicant]
US 10740638B1 · Annis · 2020 [cited by applicant]
US 10932673B2 · Addison et al. · 2021 [cited by applicant]
US 11026586B2 · Addison et al. · 2021 [cited by applicant]
US 11102304B1 · Jain et al. · 2021 [cited by applicant]
US 20050015009A1 · Mourad et al. · 2005 [cited by applicant]
US 20070293760A1 · Schaafsma · 2007 [cited by applicant]
US 20090326386A1 · Sethi et al. · 2009 [cited by applicant]
US 20110105912A1 · Widmar et al. · 2011 [cited by applicant]
US 20110201911A1 · Johnson et al. · 2011 [cited by applicant]
US 20150327779A1 · Breskin et al. · 2015 [cited by applicant]
US 20160196384A1 · Mansi et al. · 2016 [cited by applicant]
US 20160242700A1 · Ferber et al. · 2016 [cited by applicant]
US 20160324425A1 · Addison et al. · 2016 [cited by applicant]
US 20160367197A1 · Addison et al. · 2016 [cited by applicant]
US 20170095161A1 · Addison et al. · 2017 [cited by applicant]
US 20170105631A1 · Addison et al. · 2017 [cited by applicant]
US 20170105671A1 · Borgos · 2017 [cited by applicant]
US 20170196501A1 · Watson et al. · 2017 [cited by applicant]
US 20180014791A1 · Montgomery et al. · 2018 [cited by applicant]
US 20180020991A1 · Aung et al. · 2018 [cited by applicant]
US 20180049649A1 · Addison et al. · 2018 [cited by applicant]
US 20180070831A1 · Sutin et al. · 2018 [cited by applicant]
US 20180110455A1 · Chang et al. · 2018 [cited by applicant]
US 20180249916A1 · Bienek et al. · 2018 [cited by applicant]
US 20180338731A1 · Addison et al. · 2018 [cited by applicant]
US 20190328241A1 · Addison et al. · 2019 [cited by applicant]
US 20200107763A1 · Antunes et al. · 2020 [cited by applicant]
US 20200129076A1 · Montgomery et al. · 2020 [cited by applicant]
US 20200146636A1 · Addison · 2020 [cited by applicant]
US 20200187866A1 · Antunes et al. · 2020 [cited by applicant]
US 20200251201A1 · Tlan · 2020 [cited by applicant]
US 20200349707A1 · Hosseini · 2020 [cited by examiner]
US 20210177275A1 · Addison et al. · 2021 [cited by applicant]
US 20210225463A1 · Knighton, Jr. · 2021 [cited by examiner]
US 20220213558A1 · Levin et al. · 2022 [cited by applicant]
WO 2017001023A1 · 2017 [cited by applicant]
Brady, K., Joshi, B., Zweifel, C., Smielewski, P., Czosnyka, M., Easley, R. B., & Hogue, C. W. (2010). Real-time continuous monitoring of cerebral blood flow autoregulation using near-infrared spectroscopy in patients u… [cited by examiner]
Chuan et al., “Is Cerebrovascular Autoregulation Associated with Outcomes After Major Noncardiac Surgery? A Prospective Observational Pilot Study,” Acta Anaesthesiologica Scandinavica, Jul. 11, 2018, 10 pp. [cited by applicant]
Mohamadlou et al., “Prediction of Acute Kidney Injury with a Machine Learning Algorithm using Electronic Health Record Data,” Canadian Journal of Kidney Health and Disease, vol. 5, Nov. 22, 2017, 9 pp. [cited by applicant]
Prqugh, MD, et al., “Monitoring the Brain to Save the Kidneys” Publication info: Critical Care Medicine, Feb. 2013, vol. 41, No. 2, pp. 671-673. [cited by applicant]
Scheeran et al., “Journal of Clinical Monitoring and Computing 2016 End of Year Summary: Monitoring Cerebral Oxygenation and Autoregulation,” Springer Science and Business Media, Journal of Clinical Monitoring and Compu… [cited by applicant]
Tsalach et al., “Cerebral Autoregulation Real-Time Monitoring,” PLoS ONE vol. 11, No. 8, Aug. 29, 2016, 27 pp. [cited by applicant]
U.S. Appl. No. 17/354,811, filed Jun. 22, 2021, naming inventors Montgomery et al. [cited by applicant]
Addison et al., “Gradient adjustment method for better discriminating correlating and non-correlating regions of physiological signals: application to the partitioning of impaired and intact zones of cerebral autoregula… [cited by applicant]
International Search Report and Written Opinion of International Application No. PCT/US2022/071240 dated Jun. 21, 2022, 17 pp. [cited by applicant]
Malykhina et al., “Digitalization of medical services for detecting violations of cerebrovascular regulation based on a neural network signal analysis algorithm”, Proceedings of the 2nd International Scientific Conferen… [cited by applicant]